Trial Profile
Phase I trial of TRB N0224 in patients with osteoarthritis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 12 Sep 2014
Price :
$35
*
At a glance
- Drugs TRB N0224 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 12 Sep 2014 New trial record
- 29 Jul 2014 The Feinstein Institute for Medical Research, in partnership with Traverse Biosciences, received an award from the National Institute on Aging which will support this study, according to a North Shore Long Island Jewish Health System media release.